3D bioprinted epicardial patch of GelMA containing VEGF-loaded chitosan nanoparticles and human bone marrow mesenchymal stem cells for the treatment of myocardial infarction
- 3 December 2025
- journal article
- Published by IOP Publishing in Biofabrication
- Vol. 18 (1) , 015010
Abstract
The transplantation of human bone marrow mesenchymal stem cells (hMSCs) exhibits promising therapeutic effects in the treatment of myocardial infarction (MI), however, its clinical application is limited due to the low survival rate of the transplanted cells. Three-dimensional (3D) bioprinted tissue engineering patches have demonstrated efficacy as a delivery approach to enhance the viability and engraftment of stem cells. In this study, we have developed a novel hMSCs tissue-engineered patch equipped with a nano-slow-release system using 3D bioprinting technology. The patch is based on a matrix material consisting of methacrylated gelatin (GelMA) and chitosan nanoparticles loaded with vascular endothelial growth factor (VEGF), which possesses pro-angiogenic effects. The resulting patch demonstrated excellent compatibility with hMSCs and enabled stable, sustained VEGF release. In vivo results showed that the patch significantly reduced cardiomyocyte apoptosis three days after MI, and improved cardiac function and myocardial fibrosis at 28 d post-surgery. These effects were closely associated with the patch’s potent angiogenic properties and favorable stem cell survival. In conclusion, this study successfully developed a 3D-printed tissue engineering patch with strong potential for clinical application, offering a promising new approach for the treatment of MI.Keywords
Funding Information
- Wu Jieping Medical Foundation (320.6750.2022-11-26)
- National Natural Science Foundation, China (81770347)
- Project of Key Laboratory of Preservation of Human Genetic Resources and Disease Control of China, Ministry of Education (LPHGRD2022-002)
- Heilongjiang Province Natural Science Foundation, China (JJ2024LH1923)
- Fundamental research funds for the provincial universities of Heilongjiang (2020-KYYWF-1452)
This publication has 41 references indexed in Scilit:
- A Bioprinted Cardiac Patch Composed of Cardiac‐Specific Extracellular Matrix and Progenitor Cells for Heart RepairAdvanced Healthcare Materials, 2018
- Epicardial application of cardiac progenitor cells in a 3D-printed gelatin/hyaluronic acid patch preserves cardiac function after myocardial infarctionBiomaterials, 2015
- Cardiac extracellular matrix–fibrin hybrid scaffolds with tunable properties for cardiovascular tissue engineeringActa Biomaterialia, 2015
- Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation techniqueColloids and Surfaces B: Biointerfaces, 2012
- Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cellsBiomaterials, 2012
- Stem Cell Engraftment and Survival in the Ischemic HeartThe Annals of Thoracic Surgery, 2011
- Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammationBasic Research in Cardiology, 2011
- Biodegradable polymeric nanoparticles based drug delivery systemsColloids and Surfaces B: Biointerfaces, 2010
- Chitosan-based delivery systems for protein therapeutics and antigensAdvanced Drug Delivery Reviews, 2010
- Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriersJournal of Applied Polymer Science, 1997